Organization | Glaucoma Research Society of Canada

Glaucoma Research Society of Canada Report issue

Academic/Hospital Phase 4

Founded: Toronto Canada (1997)

Organization Overview

First Clinical Trial

2007

NCT00485108

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Glaucoma Research Society of Canada

Active Ingredients

Drugs in Phase 4 Trials (3)

bevacizumab (avastin) (1 trial)

bromfenac (xibrom) (1 trial)

dexamethasone (1 trial)

Drugs in Other Trials (5)

beclomethasone (vanceril) (1 trial)

ketorolac (acuvail) (1 trial)

metilcelulosa (1 trial)

prednisone (meticorten) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Glaucoma (Phase 4)

Optic Nerve Diseases (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 8